Ami Organics raises Rs. 400 crores through QIP
The Issue opened on June 18, 2024 and closed on June 21, 2024
The Issue opened on June 18, 2024 and closed on June 21, 2024
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
DSP-5336, an Investigational Menin and Mixed-lineage Leukemia Inhibitor, is Being Evaluated in Patients with Relapsed or Refractory Acute Leukemia
This clearance is a foundational step in Roche's commitment to enable routine clinical diagnosis with its digital pathology solutions
This strategic decision will unlock significant value for our scientific and industrial products business
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
Merck shared updates on the company’s oncology pipeline and focused R&D approach
The HD21 study adds to the body of evidence supporting ADCETRIS as a backbone agent in the treatment of specific lymphomas
PIVOTAL is an open label, randomized, multicenter, Phase III trial evaluating Nidlegy as a neoadjuvant intralesional therapy
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Subscribe To Our Newsletter & Stay Updated